Mylan commercially launches Remdesivir under brand name DESREM in India
Mylan received license from Gilead for commercialisation of Remdesivir
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Home » DESREM
Browsing Tag
DESREM
Mylan to launch COVID-19 remdisivir drug in India for Rs 4,800
Secures regulatory approval for Remdesivir Lyophilsed Powder for injection 100 mg/vial in India
Mylan announced that the Drug…